 |
 |

Effect of Central Corneal Thickness on Dynamic Contour Tonometry and Goldmann Applanation Tonometry in Primary Open-angle Glaucoma
Matthias C. Grieshaber, MD;
Andreas Schoetzau, MS;
Claudia Zawinka, MD;
Josef Flammer, MD;
Selim Orgul, MD
Arch Ophthalmol. 2007;125(6):740-744.
ABSTRACT
 |  |
Objective To compare the dependence of dynamic contour tonometry (DCT) and Goldmann applanation tonometry (GAT) on central corneal thickness (CCT) in primary open-angle glaucoma.
Methods In a prospective study, the interocular (right vs left eye) difference in intraocular pressure measured by DCT and GAT was compared with the interocular CCT difference in 125 patients with primary open-angle glaucoma.
Results Dynamic contour tonometry measurements (mean ± SD, 19.4 ± 4.1 mm Hg) were significantly (P = .004) higher than GAT measurements (mean ± SD, 15.5 ± 3.4 mm Hg), correlating significantly with each other (r2 = 0.82, P<.001). The interocular difference in intraocular pressure correlated significantly with the interocular CCT difference for GAT (r = 0.30, P = .001) and DCT (r = 0.23, P = .02) readings. Dynamic contour tonometry and GAT intraocular pressure differences significantly increased with older age (slope, 0.033 [95% confidence interval, 0.002-0.064] mm Hg/y; P =.03) but not with thicker CCT (slope, 0.006 [95% confidence interval, –0.003 to 0.017] mm Hg/µm; P =.22).
Conclusions In this series, GAT and DCT measurements were dependent on CCT in patients with primary open-angle glaucoma. Because intraocular pressure differences between DCT and GAT were independent of CCT, DCT and GAT are susceptible to similar measurement biases depending on CCT.
INTRODUCTION
Elevated intraocular pressure (IOP) is generally regarded as one of the major risk factors for glaucoma, and its reduction is the most frequently used surrogate of successful management of risk factors. For that reason, accurate IOP is a fundamental variable in clinical practice.
Goldmann applanation tonometry (GAT) is the gold standard for measurement of IOP. However, its accuracy depends on many factors, including corneal thickness and other biomechanical properties.1-2 Goldmann and Schmidt3 calibrated the tonometer for a mean central corneal thickness (CCT) of 520 µm, knowing that the tonometer may be inaccurate in corneas differing from that value. Several studies4-7 have reported that most patients with ocular hypertension have a high CCT, which may lead to a spuriously high IOP measured using an applanation device rather than truly elevated IOP. Other studies6, 8-10 found that patients with normal-tension glaucoma have thinner corneas than those of the general population. Therefore, patients with normal-tension glaucoma may have a higher IOP than measured. Furthermore, a thin cornea may be an independent risk factor for the conversion to primary open-angle glaucoma (POAG) in patients with ocular hypertension,11 although such an effect has been called into question. For this reason, it is controversial whether CCT is an independent risk factor for progression of established glaucoma.12-14 The effect of CCT and other corneal abnormalities on the accuracy of GAT continues to be one of the most important drawbacks of tonometry15 and may influence management decisions in clinical practice. For accurate GAT assessment of IOP, measurement of CCT using an ultrasound pachymeter and nomograms for adjustment of GAT readings has been suggested.4 Unfortunately, none of the correction tables seem to be reliable or satisfactory.16-17
To reduce the corneal effect on IOP measurement and to improve IOP assessment, dynamic contour tonometry (DCT) with a new digital and nonapplanation contact tonometer was developed (Swiss Microtechnology AG, Port, Switzerland). According to the manufacturer18 and recent studies19-20 on cadaver eyes, DCT measurements are minimally dependent on structural properties of the cornea, particularly CCT. The concave surface of the tonometer tip matches the contour of the cornea; this contour matching creates equilibrium between capillary force, rigidity force, appositional force, and force exerted on the cornea by IOP. A piezoelectric sensor integrated into the contoured surface of the tip measures IOP without systematic errors caused by these forces or by changes in the corneal biomechanical properties.21
Recently, the effect of CCT on DCT and GAT measurements has been investigated in healthy eyes. In some studies,22-23 GAT was significantly more affected than DCT by CCT, while in another study24 there was no significant difference between GAT and DCT. The objective of the present study was to assess the relationship between IOP measurement and CCT. In contrast to previous studies22-24 comparing DCT and GAT, we assessed patients with POAG. In addition, to avoid the influence of interindividual factors on IOP, we used a novel approach considering the interocular effect of CCT on IOP measurements.
METHODS
DESIGN
In a prospective single-center study, 125 consecutive patients with POAG were recruited from the glaucoma unit of the Department of Ophthalmology, University Hospital Basel, Basel, Switzerland, during a 6-month period between November 1, 2004, and April 30, 2005. Excluded were patients with pseudoexfoliation, a history of trauma, pigmentary dispersion, narrow or closed iridocorneal angle, evidence of any secondary glaucoma, any type of preceding refractive surgery and corneal disease, and chronic or recurrent inflammatory eye disease (eg, scleritis or uveitis). In addition, patients with poor cooperation, poor quality of DCT readings, and unreliable measurements due to astigmatism greater than 2 diopters were also excluded. All patients underwent 5 tonometric measurements (2 GAT readings, followed by 3 DCT readings).25-26 After each GAT measurement, a rest period of 3 minutes was allowed to minimize the tonographic effects of applanation tonometry. The mean IOP reading for each measurement method was recorded. Because DCT provides a digital readout of IOP on a liquid crystal display (LCD), prior knowledge of GAT values would not affect the result and made it mandatory to perform GAT measurements first for masking reasons. The right eye was always measured first. After application of topical anesthesia to the cornea, a paper stripe impregnated with fluorescein was used to stain the precorneal tear film immediately before IOP measurement. The patient was asked to blink before measurement to ensure equal distribution. Goldmann applanation tonometry was performed using a slitlamp (Haag-Streit, Koeniz, Switzerland) with a tonometer calibrated according to the manufacturer's guidelines.18 If IOP fluctuated during the cardiac pulse cycle, GAT measurements were taken in the middle of the pulsation amplitude. Intraocular pressure readings by DCT were computed and displayed by the instrument, thereby reducing possible observer bias. Dynamic contour tonometry provides 5 different quality levels, with 1 being the best and 5 being the poorest. As recommended by the manufacturer, only measurements of quality 3 or less were evaluated and included in the study.18 In addition, CCT was measured immediately after IOP measurements using an ultrasonic pachymeter (SP-3000; Tomey Corporation, Cambridge, Mass). The mean of 5 readings within a range of ±5 µm was used for each eye for analysis.
STATISTICAL ANALYSIS
Correlation analysis between the mean DCT and GAT measurements and CCT was performed using Pearson product moment correlation coefficient (SPSS Inc, Chicago, Ill). The 2 IOP measurement methods studied (DCT and GAT) were further compared for bias and for agreement. Because neither of the 2 methods can at the outset be assumed to be superior to the other, the difference between GAT and DCT was plotted against the mean of the 2 methods for analysis of individual pairs according to the method by Bland and Altman.27 Intraocular pressure differences between the right and left eyes (interocular difference) for GAT and DCT readings were analyzed for correlation with the interocular CCT difference in a linear least squares regression analysis.
A linear mixed-effects model considering the 2 eyes of each patient (including CCT and IOP of both eyes) was computed. Mixed-effects models incorporated fixed and random effects. The patient was the random factor, and the eye side (right vs left) was the fixed factor varying within the patient. Central corneal thickness and mean age were covariates; CCT varied within the patient, but age did not. P<.05 was considered statistically significant.
RESULTS
Five patients (4.0%) were excluded because of previous corneal surgery or disease, and 9 patients (7.2%) were excluded because of poor cooperation or inability to obtain good-quality DCT measurements. The mean ± SD age of 111 patients with POAG was 63.8 ± 13.3 years (age range, 29-87 years). The mean ± SD CCT was 540.9 ± 42.4 µm (range, 420-650 µm [median, 539.5 µm]). The mean ± SD interocular CCT difference was 3.6 ± 12.9 µm. All patients were treated with monotherapy or combined topical therapy. The mean ± SD IOP of the 2 GAT readings was 15.5 ± 3.4 mm Hg, and the mean ± SD IOP of the 3 DCT readings was 19.4 ± 4.1 mm Hg. Dynamic contour tonometry readings were a mean ± SD of 3.9 ± 2.3 mm Hg higher than GAT readings (P = .004); after excluding 3 extreme outliers, they were a mean ± SD of 3.9 ± 1.54 mm Hg higher (P<.001) (Figure 1). The measurements of both devices were significantly correlated with each other (r = 0.82, P<.001). In the Bland-Altman plot, the difference between DCT and GAT varied with the mean (P = .003); however, after excluding the 4 smallest and largest outliers, the difference did not vary with the mean (slope, –0.011; P = .81). Per 10 mm Hg of IOP increase, the increase in the difference between DCT and GAT is –0.11 mm Hg (95% confidence interval, –1.65 to 7.65 mm Hg). This indicates parallelism between the 2 methods.
|
|
|
|
Figure 1. Bland-Altman plot of the difference between dynamic contour tonometry (DCT) and Goldmann applanation tonometry (GAT) measurements vs the mean of DCT and GAT measurements. The dotted lines indicate 95% confidence intervals for an individual; the solid line, the mean.
|
|
|
The interocular IOP difference between GAT and DCT readings showed significant correlation with the interocular CCT difference in linear least squares regression analysis (r = 0.301 [P = .001] for GAT and r = 0.228 [P = .02] for DCT) (Figure 2). The mean IOP difference between DCT and GAT readings was not dependent on CCT (P = .23), indicating a comparable dependence of GAT and DCT. In a linear mixed-effects model, the IOP difference between DCT and GAT readings significantly increased with older age (slope, 0.033 [95% confidence interval, 0.002-0.064] mm Hg/y; P =.03) but not with thicker CCT (slope, 0.006 [95% confidence interval, –0.003 to 0.017] mm Hg/µm; P = .22).
|
|
|
|
Figure 2. Interocular (right vs left eye) difference of intraocular pressure (IOP) vs interocular difference of central corneal thickness (CCT) by dynamic contour tonometry (DCT) or Goldmann applanation tonometry (GAT) (linear r2 = 0.09).
|
|
|
COMMENT
Previously published data among nonglaucomatous patients undergoing laser in situ keratomileusis suggested that the new nonapplanation DCT device depended less on CCT than GAT.25-26,28 In another study29 among healthy subjects, DCT measurements were independent of CCT. The present study investigated whether DCT measurements are less dependent on CCT compared with GAT in patients with POAG when a novel approach considering the interocular effect of CCT on IOP measurements was applied.
There was significant correlation between IOP and CCT using either device. In addition, the interocular difference between DCT and GAT readings was not dependent on CCT, suggesting (to our knowledge) a hitherto undescribed parallelism of the relationship between IOP and CCT using either device. In contrast to healthy subjects, patients with POAG have increased IOP, which is independent of CCT. This may have in part contributed to the present results. Furthermore, the corneal rigidity in patients with glaucoma may be altered primarily or secondarily to topical drugs, possibly affecting IOP measurements, as some antiglaucomatous drugs may modulate the extracellular matrix.30 Therefore, the potential advantage of DCT relative to CCT independence may not hold true for patients with POAG.
Intraocular pressure measured using DCT was consistently higher compared with GAT measurements in human cadaver eyes,19 in eyes undergoing refractive surgery,25, 28 and in healthy eyes.24 Intraocular pressure differences between DCT and GAT measurements may be attributed to calibration of DCT, which is based on a manometrically controlled pressure and not on applanation.25 Intraocular pressure obtained by GAT has been found to be lower than true IOP as measured intracamerally.31-32 Furthermore, to our knowledge, no significant difference between DCT readings and manometric IOP readings has been found in human cadaver eyes.19-20
The mean IOP difference between DCT and GAT readings in this study is the highest reported in the literature (3.9 mm Hg). At present, it is unclear why the difference in this study population is so large. Recent studies have shown that IOP differences between DCT and GAT are small (0.7-1.0 mm Hg) in nonglaucomatous subjects23-24 and are larger (1.7-2 mm Hg) in studies29, 33 that include patients with glaucoma. However, a study29 differentiating between patients who had glaucoma and those who did not have glaucoma did not find different results between the 2 groups. In the present study, all patients with POAG had been receiving 1 or 2 topical antiglaucoma eyedrops for months or years. Therefore, we cannot exclude that the use of eyedrops may have had an effect on corneal biomechanics and accordingly on IOP measurement. However, we did not subgroup patients with POAG according to different medication use because of the heterogeneity of the drugs used and the statistical weakness of such stratification. In previous studies,34-35 no significant relationship between CCT and the use of some topical IOP-lowering drugs has been reported. Nevertheless, it remains to be elucidated whether various topical glaucoma medications might confound the relationship between CCT and IOP. Likewise, whether there is an effect of topical drugs on biomechanical properties of the cornea other than CCT needs further validation, as there is evidence that some IOP-lowering drugs may alter tissue36-37 by stimulating the degradation of extracellular maxtrix (eg, modulation of matrix metalloproteinases in conjunctival and subconjunctival tissue).30 In addition, CCT is only a surrogate for corneal rigidity. A thicker cornea does not necessarily mean higher rigidity of the cornea in all patients, and corneal factors other than CCT may play a role in the corneal biomechanics affecting IOP readings, such as hydration state,20, 38 curvature,38 and age of the patient.39-40
In this analysis, we used an interocular study design that has not been described previously, to our knowledge. The advantage of an interocular or intraindividual comparison is minimal interference from other nonocular factors in different individuals. Corneal structure or biomechanics varies among patients even when CCT is the same. Therefore, consideration of CCT from different patients does not necessarily allow conclusions on the effect of CCT on IOP. From a statistical point of view, the interocular design increases efficiency, with greater degrees of freedom than an interindividual comparison.
Seven percent of patients were excluded from the analysis because of the inability to obtain good-quality DCT. Some patients were unable to sit completely still, breathe quietly, and avoid slight movements of the eye or head. The fact that DCT requires a longer time of measurement than GAT (ie, approximately 5 cardiac cycles) could be regarded as a disadvantage of DCT, particularly in the older patient. However, the promising advantages of DCT are the short learning curve, the ease of use of DCT in most patients in our experience, and the low intraobserver and interobserver variability because of semiautomatic recording.41
In conclusion, DCT measurements of IOP depended at least as much on CCT as GAT measurements but were significantly higher than GAT measurements in patients with POAG. Because IOP differences between DCT and GAT were independent of CCT, the measurement devices are susceptible to similar measurement biases depending on CCT, at least in patients with POAG.
AUTHOR INFORMATION
Correspondence: Matthias C. Grieshaber, MD, Department of Ophthalmology, University Hospital Basel, Mittlere Strasse 91, PO Box, CH-4031 Basel, Switzerland (mgrieshaber{at}uhbs.ch).
Submitted for Publication: April 13, 2006; final revision received November 2, 2006; accepted November 3, 2006.
Financial Disclosure: None reported.
Author Affiliations: Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.
REFERENCES
 |  |
1. Whitacre MM, Stein R. Sources of error with use of Goldmann-type tonometers. Surv Ophthalmol. 1993;38:1-30.
FULL TEXT
| PUBMED
2. Herndon LW, Choudhri SA, Cox T, Damji KF, Shields MB, Allingham RR. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol. 1997;115:1137-1141.
ABSTRACT
3. Goldmann H, Schmidt T. Applanation tonometry [in German]. Ophthalmologica. 1957;134:221-242.
PUBMED
4. Argus WA. Ocular hypertension and central corneal thickness. Ophthalmology. 1995;102:1810-1812.
ISI
| PUBMED
5. Bron AM, Creuzot-Garcher C, Goudeau-Boutillon S, dAthis P. Falsely elevated intraocular pressure due to increased central corneal thickness. Graefes Arch Clin Exp Ophthalmol. 1999;237:220-224.
FULL TEXT
|
ISI
| PUBMED
6. Copt RP, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol. 1999;117:14-16.
FREE FULL TEXT
7. Herman DC, Hodge DO, Bourne WM. Increased corneal thickness in patients with ocular hypertension. Arch Ophthalmol. 2001;119:334-336.
FREE FULL TEXT
8. Shah S, Chatterjee A, Mathai M; et al. Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology. 1999;106:2154-2160.
FULL TEXT
|
ISI
| PUBMED
9. Ehlers N, Hansen FK. Central corneal thickness in low-tension glaucoma. Acta Ophthalmol (Copenh). 1974;52:740-746.
PUBMED
10. Stodtmeister R. Applanation tonometry and correction according to corneal thickness. Acta Ophthalmol Scand. 1998;76:319-324.
FULL TEXT
|
ISI
| PUBMED
11. Gordon MO, Beiser JA, Brandt JD; et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-730.
FREE FULL TEXT
12. Medeiros FA, Sample PA, Zangwill LM, Bowd C, Aihara M, Weinreb RN. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol. 2003;136:805-813.
FULL TEXT
|
ISI
| PUBMED
13. Herndon LW, Weizer JS, Stinnett SS. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol. 2004;122:17-21.
FREE FULL TEXT
14. Chauhan BC, Hutchison DM, LeBlanc RP, Artes PH, Nicolela MT. Central corneal thickness and progression of the visual field and optic disc in glaucoma. Br J Ophthalmol. 2005;89:1008-1012.
FREE FULL TEXT
15. Damji KF, Muni RH, Munger RM. Influence of corneal variables on accuracy of intraocular pressure measurement. J Glaucoma. 2003;12:69-80.
FULL TEXT
|
ISI
| PUBMED
16. Shah S. Accurate intraocular pressure measurement: the myth of modern ophthalmology? Ophthalmology. 2000;107:1805-1807.
FULL TEXT
|
ISI
| PUBMED
17. Lee GA, Khaw PT, Ficker LA, Shah P. The corneal thickness and intraocular pressure story: where are we now? Clin Experiment Ophthalmol. 2002;30:334-337.
FULL TEXT
|
ISI
| PUBMED
18. Manufacturer's Manual. Version 7.4. Port, Switzerland: SMT Swiss Microtechnology AG; 2004.19. Kniestedt C, Nee M, Stamper RL. Dynamic contour tonometry: a comparative study on human cadaver eyes. Arch Ophthalmol. 2004;122:1287-1293.
FREE FULL TEXT
20. Kniestedt C, Nee M, Stamper RL. Accuracy of dynamic contour tonometry compared with applanation tonometry in human cadaver eyes of different hydration states. Graefes Arch Clin Exp Ophthalmol. 2005;243:359-366.
FULL TEXT
|
ISI
| PUBMED
21. Kanngiesser HE, Kniestedt C, Robert YC. Dynamic contour tonometry: presentation of a new tonometer. J Glaucoma. 2005;14:344-350.
FULL TEXT
|
ISI
| PUBMED
22. Kniestedt C, Lin S, Choe J, Bostrom A, Nee M, Stamper RL. Clinical comparison of contour and applanation tonometry and their relationship to pachymetry. Arch Ophthalmol. 2005;123:1532-1537.
FREE FULL TEXT
23. Kotecha A, White ET, Shewry JM, Garway-Heath DF. The relative effects of corneal thickness and age on Goldmann applanation tonometry and dynamic contour tonometry. Br J Ophthalmol. 2005;89:1572-1575.
FREE FULL TEXT
24. Pache M, Wilmsmeyer S, Lautebach S, Funk J. Dynamic contour tonometry versus Goldmann applanation tonometry: a comparative study. Graefes Arch Clin Exp Ophthalmol. 2005;243:763-767.
FULL TEXT
|
ISI
| PUBMED
25. Kaufmann C, Bachmann LM, Thiel MA. Intraocular pressure measurements using dynamic contour tonometry after laser in situ keratomileusis. Invest Ophthalmol Vis Sci. 2003;44:3790-3794.
FREE FULL TEXT
26. Siganos DS, Papastergiou GI, Moedas C. Assessment of the Pascal dynamic contour tonometer in monitoring intraocular pressure in unoperated eyes and eyes after LASIK. J Cataract Refract Surg. 2004;30:746-751.
FULL TEXT
|
ISI
| PUBMED
27. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
FULL TEXT
|
ISI
| PUBMED
28. Duba I, Wirthlin AC. Dynamic contour tonometry for post-LASIK intraocular pressure measurements. Klin Monatsbl Augenheilkd. 2004;221:347-350.
FULL TEXT
| PUBMED
29. Kamppeter BA, Jonas JB. Dynamic contour tonometry for intraocular pressure measurement. Am J Ophthalmol. 2005;140:318-320.
FULL TEXT
|
ISI
| PUBMED
30. Ito T, Ohguro H, Mamiya K, Ohguro I, Nakazawa M. Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissue. Invest Ophthalmol Vis Sci. 2006;47:823-830.
FREE FULL TEXT
31. Feltgen N, Leifert D, Funk J. Correlation between central corneal thickness, applanation tonometry, and direct intracameral IOP readings. Br J Ophthalmol. 2001;85:85-87.
FREE FULL TEXT
32. Marx W, Madjlessi F, Reinhard T, Althaus C, Sundmacher R. More than 4 years' experience with electronic intraocular needle tonometry [in German]. Ophthalmologe. 1999;96:498-502.
FULL TEXT
|
ISI
| PUBMED
33. Ku JY, Danesh-Meyer HV, Craig JP, Gamble GD, McGhee CN. Comparison of intraocular pressure measured by Pascal dynamic contour tonometry and Goldmann applanation tonometry. Eye. 2006;20:191-198.
FULL TEXT
|
ISI
| PUBMED
34. Korey M, Gieser D, Kass MA, Waltman SR, Gordon M, Becker B. Central corneal endothelial cell density and central corneal thickness in ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol. 1982;94:610-616.
ISI
| PUBMED
35. Wang JJ, Mitchell P, Simpson JM, Cumming RG, Smith W. Visual impairment, age-related cataract, and mortality. Arch Ophthalmol. 2001;119:1186-1190.
FREE FULL TEXT
36. Sherwood MB, Grierson I, Millar L, Hitchings RA. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology. 1989;96:327-335.
ISI
| PUBMED
37. Baudouin C, Pisella PJ, Fillacier K; et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology. 1999;106:556-563.
FULL TEXT
|
ISI
| PUBMED
38. Liu J, Roberts CJ. Influence of corneal biomechanical properties on intraocular pressure measurement: quantitative analysis. J Cataract Refract Surg. 2005;31:146-155.
FULL TEXT
|
ISI
| PUBMED
39. Malik NS, Moss SJ, Ahmed N, Furth AJ, Wall RS, Meek KM. Ageing of the human corneal stroma: structural and biochemical changes. Biochim Biophys Acta. 1992;1138:222-228.
PUBMED
40. Sherrard ES, Novakovic P, Speedwell L. Age-related changes of the corneal endothelium and stroma as seen in vivo by specular microscopy. Eye. 1987;1:197-203.
ISI
| PUBMED
41. Kaufmann C, Bachmann LM, Thiel MA. Comparison of dynamic contour tonometry with Goldmann applanation tonometry. Invest Ophthalmol Vis Sci. 2004;45:3118-3121.
FREE FULL TEXT
|